219 related articles for article (PubMed ID: 25241033)
1. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.
Sherman SK; Maxwell JE; Carr JC; Wang D; Bellizzi AM; Sue O'Dorisio M; O'Dorisio TM; Howe JR
Clin Exp Metastasis; 2014 Dec; 31(8):935-44. PubMed ID: 25241033
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.
Carr JC; Sherman SK; Wang D; Dahdaleh FS; Bellizzi AM; O'Dorisio MS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S739-S746. PubMed ID: 24114056
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling.
Carr JC; Boese EA; Spanheimer PM; Dahdaleh FS; Martin M; Calva D; Schafer B; Thole DM; Braun T; O'Dorisio TM; O'Dorisio MS; Howe JR
Surgery; 2012 Dec; 152(6):998-1007. PubMed ID: 23158174
[TBL] [Abstract][Full Text] [Related]
4. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.
Scott AT; Pelletier D; Maxwell JE; Sherman SK; Keck KJ; Li G; Dillon JS; O'Dorisio TM; Bellizzi AM; Howe JR
Ann Surg Oncol; 2019 Aug; 26(8):2525-2532. PubMed ID: 31011904
[TBL] [Abstract][Full Text] [Related]
5. Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors.
Sherman SK; Carr JC; Wang D; O'Dorisio MS; O'Dorisio TM; Howe JR
Surgery; 2013 Dec; 154(6):1206-13; discussion 1214. PubMed ID: 24238043
[TBL] [Abstract][Full Text] [Related]
6. A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors.
Maxwell JE; Sherman SK; Stashek KM; O'Dorisio TM; Bellizzi AM; Howe JR
Surgery; 2014 Dec; 156(6):1359-65; discussion 1365-6. PubMed ID: 25456909
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.
Miller HC; Frampton AE; Malczewska A; Ottaviani S; Stronach EA; Flora R; Kaemmerer D; Schwach G; Pfragner R; Faiz O; Kos-Kudła B; Hanna GB; Stebbing J; Castellano L; Frilling A
Endocr Relat Cancer; 2016 Sep; 23(9):711-26. PubMed ID: 27353039
[TBL] [Abstract][Full Text] [Related]
8. Pancreastatin predicts survival in neuroendocrine tumors.
Sherman SK; Maxwell JE; O'Dorisio MS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2014 Sep; 21(9):2971-80. PubMed ID: 24752611
[TBL] [Abstract][Full Text] [Related]
9. Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastases.
Keck KJ; Breheny P; Braun TA; Darbro B; Li G; Dillon JS; Bellizzi AM; O'Dorisio TM; Howe JR
Surgery; 2018 Jan; 163(1):232-239. PubMed ID: 29154080
[TBL] [Abstract][Full Text] [Related]
10. GIPR expression in gastric and duodenal neuroendocrine tumors.
Sherman SK; Maxwell JE; Carr JC; Wang D; O'Dorisio MS; O'Dorisio TM; Howe JR
J Surg Res; 2014 Aug; 190(2):587-93. PubMed ID: 24565507
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.
Spolverato G; Bagante F; Aldrighetti L; Poultsides G; Bauer TW; Field RC; Marques HP; Weiss M; Maithel SK; Pawlik TM
J Gastrointest Surg; 2017 Dec; 21(12):2039-2047. PubMed ID: 28744737
[TBL] [Abstract][Full Text] [Related]
12. The value of preoperative imaging in small bowel neuroendocrine tumors.
Dahdaleh FS; Lorenzen A; Rajput M; Carr JC; Liao J; Menda Y; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2013 Jun; 20(6):1912-7. PubMed ID: 23283442
[TBL] [Abstract][Full Text] [Related]
13. Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling.
Tran CG; Scott AT; Li G; Sherman SK; Ear PH; Howe JR
Surgery; 2021 Jan; 169(1):155-161. PubMed ID: 32611516
[TBL] [Abstract][Full Text] [Related]
14. Is Multifocality an Indicator of Aggressive Behavior in Small Bowel Neuroendocrine Tumors?
Choi AB; Maxwell JE; Keck KJ; Bellizzi AJ; Dillon JS; OʼDorisio TM; Howe JR
Pancreas; 2017 Oct; 46(9):1115-1120. PubMed ID: 28902780
[TBL] [Abstract][Full Text] [Related]
15. Comparative single-cell RNA sequencing (scRNA-seq) reveals liver metastasis-specific targets in a patient with small intestinal neuroendocrine cancer.
Rao M; Oh K; Moffitt R; Thompson P; Li J; Liu J; Sasson A; Georgakis G; Kim J; Choi M; Powers S
Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32054662
[TBL] [Abstract][Full Text] [Related]
16. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling.
Starzyńska T; Karczmarski J; Paziewska A; Kulecka M; Kuśnierz K; Żeber-Lubecka N; Ambrożkiewicz F; Mikula M; Kos-Kudła B; Ostrowski J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586046
[TBL] [Abstract][Full Text] [Related]
17. Aberration of ARID1A Is Associated With the Tumorigenesis and Prognosis of Sporadic Nonfunctional Pancreatic Neuroendocrine Tumors.
Han X; Chen W; Chen P; Zhou W; Rong Y; Lv Y; Li JA; Ji Y; Chen W; Lou W; Xu X
Pancreas; 2020 Apr; 49(4):514-523. PubMed ID: 32282764
[TBL] [Abstract][Full Text] [Related]
18. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.
Duerr EM; Mizukami Y; Ng A; Xavier RJ; Kikuchi H; Deshpande V; Warshaw AL; Glickman J; Kulke MH; Chung DC
Endocr Relat Cancer; 2008 Mar; 15(1):243-56. PubMed ID: 18310291
[TBL] [Abstract][Full Text] [Related]
19. Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
Li SC; Essaghir A; Martijn C; Lloyd RV; Demoulin JB; Oberg K; Giandomenico V
Mod Pathol; 2013 May; 26(5):685-96. PubMed ID: 23328977
[TBL] [Abstract][Full Text] [Related]
20. Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.
Gibson WE; Gonzalez RS; Cates JMM; Liu E; Shi C
Hum Pathol; 2018 Sep; 79():109-115. PubMed ID: 29763717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
